sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Biotechnology / MicroRNA

MicroRNA Market By Application(Clinical Diagnostics and Research) and By End Use(Research and Academic Institutes, Contract Research Organizations, Biopharmaceutical Companies, and Diagnostic Centers):Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Mar-2020
  • Total Pages: 180
  • Report Code: FAF-766
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the MicroRNA industry. The report analyzes and declares the historical and current trends analysis of the MicroRNA industry and subsequently recommends the projected trends anticipated to be observed in the MicroRNA market during the upcoming years.

The MicroRNA market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entireMicroRNA market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the MicroRNA industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the MicroRNA industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the MicroRNA market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the MicroRNA industry. The MicroRNA market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the MicroRNAsector. Key strategic developments in the MicroRNA market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the MicroRNA market are appropriately highlighted in the report.

The move from platform technology to applications is expected to fuel the market. The development of drugs and biologics across virtual drug development systems provides significant advantages over traditional models, such as reducing risk and overhead costs in combination with conventional technologies. MirNAs play a significant role in various biological processes, such as time-control development, cell proliferation, apoptosis, stem cell maintenance, differentiation, signal pathways, and pathogenesis, such as carcinogenesis. During the forecast period, this factor is expected to increase the market growth.

The MicroRNA market research report delivers an acutevaluationand taxonomy of the MicroRNA industry by practically splitting the market on the basis of different applications, end-use, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the MicroRNA industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the MicroRNA industry is provided for the leading economies of the world.

The MicroRNA market is segmented based on application and end-use. On the basis of application segmentation, the market is classified into clinical diagnostics and research. In terms of end-use segmentation, the market is bifurcated into research and academic institutes, contract research organizations, biopharmaceutical companies, and diagnostic centers.

Some of the major players operating in the MicroRNA marketareAffymetrix, Alnylam Pharmaceuticals Inc.,AstraZeneca Pharmaceuticals LP, Santaris Pharma, Biogen Idec Inc., Exiqon, Pfizer Inc., CBC Biomarker Center GmbH, Eli Lilly and Co., F. Hoffman-La Roche, GlaxoSmithKline, Novartis AG, and Merck & Co., and others.

The taxonomy of the MicroRNA industry by its scope and segmentation is as follows:

Global MicroRNA Market: By ApplicationSegmentation Analysis(Customizable)

  • Clinical Diagnostics
  • Research

Global MicroRNA Market: By End-Use Segmentation Analysis(Customizable)

  • Research and Academic Institutes
  • Contract Research Organizations
  • Biopharmaceutical Companies
  • Diagnostic Centres

Global MicroRNA Market: Regional Segmentation Analysis(Customizable)

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises abuoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. MicroRNA market – Application Analysis
    1. 2.1. Global MicroRNA Market – Application Overview
    2. 2.2. Global MicroRNA Market Share, by Application, 2019 & 2026 (USD Million)
    3. 2.3. Clinical Diagnostics
      1. 2.3.1. Global Clinical Diagnostics MicroRNA Market, 2016-2019 (USD Million)
    4. 2.4. Research
      1. 2.4.1. Global Research MicroRNA Market, 2016-2019 (USD Million)
  3. CHAPTER 3. MicroRNA market – End Use Analysis
    1. 3.1. Global MicroRNA Market – End Use Overview
    2. 3.2. Global MicroRNA Market Share, by End Use, 2019 & 2026 (USD Million)
    3. 3.3. Research and Academic Institutes
      1. 3.3.1. Global Research and Academic Institutes MicroRNA Market, 2016-2019 (USD Million)
    4. 3.4. Contract Research Organizations
      1. 3.4.1. Global Contract Research Organizations MicroRNA Market, 2016-2019 (USD Million)
    5. 3.5. Biopharmaceutical Companies
      1. 3.5.1. Global Biopharmaceutical Companies MicroRNA Market, 2016-2019 (USD Million)
    6. 3.6. Diagnostic Centers
      1. 3.6.1. Global Diagnostic Centers MicroRNA Market, 2016-2019 (USD Million)
  4. CHAPTER 4. MicroRNA market – Regional Analysis
    1. 4.1. Global MicroRNA Market Regional Overview
    2. 4.2. Global MicroRNA Market Share, by Region, 2019 & 2026 (Value)
    3. 4.3. North America
      1. 4.3.1. North America MicroRNA Market size and forecast, 2016-2019
      2. 4.3.2. North America MicroRNA Market, by Country, 2019 & 2026 (USD Million)
      3. 4.3.3. North America MicroRNA Market, by Application, 2016-2019
        1. 4.3.3.1. North America MicroRNA Market, by Application, 2016-2019 (USD Million)
      4. 4.3.4. North America MicroRNA Market, by End Use, 2016-2019
        1. 4.3.4.1. North America MicroRNA Market, by End Use, 2016-2019 (USD Million)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2019 (USD Million)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2019 (USD Million)
    4. 4.4. Europe
      1. 4.4.1. Europe MicroRNA Market size and forecast, 2016-2019
      2. 4.4.2. Europe MicroRNA Market, by Country, 2019 & 2026 (USD Million)
      3. 4.4.3. Europe MicroRNA Market, by Application, 2016-2019
        1. 4.4.3.1. Europe MicroRNA Market, by Application, 2016-2019 (USD Million)
      4. 4.4.4. Europe MicroRNA Market, by End Use, 2016-2019
        1. 4.4.4.1. Europe MicroRNA Market, by End Use, 2016-2019 (USD Million)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2019 (USD Million)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2019 (USD Million)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2019 (USD Million)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2019 (USD Million)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2019 (USD Million)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2019 (USD Million)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific MicroRNA Market size and forecast, 2016-2019
      2. 4.5.2. Asia Pacific MicroRNA Market, by Country, 2019 & 2026 (USD Million)
      3. 4.5.3. Asia Pacific MicroRNA Market, by Application, 2016-2019
        1. 4.5.3.1. Asia Pacific MicroRNA Market, by Application, 2016-2019 (USD Million)
      4. 4.5.4. Asia Pacific MicroRNA Market, by End Use, 2016-2019
        1. 4.5.4.1. Asia Pacific MicroRNA Market, by End Use, 2016-2019 (USD Million)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2019 (USD Million)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2019 (USD Million)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2019 (USD Million)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2019 (USD Million)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2019 (USD Million)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2019 (USD Million)
    6. 4.6. Latin America
      1. 4.6.1. Latin America MicroRNA Market size and forecast, 2016-2019
      2. 4.6.2. Latin America MicroRNA Market, by Country, 2019 & 2026 (USD Million)
      3. 4.6.3. Latin America MicroRNA Market, by Application, 2016-2019
        1. 4.6.3.1. Latin America MicroRNA Market, by Application, 2016-2019 (USD Million)
      4. 4.6.4. Latin America MicroRNA Market, by End Use, 2016-2019
        1. 4.6.4.1. Latin America MicroRNA Market, by End Use, 2016-2019 (USD Million)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2019 (USD Million)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2019 (USD Million)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2019 (USD Million)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa MicroRNA Market size and forecast, 2016-2019
      2. 4.7.2. The Middle-East and Africa MicroRNA Market, by Country, 2019 & 2026 (USD Million)
      3. 4.7.3. The Middle-East and Africa MicroRNA Market, by Application, 2016-2019
        1. 4.7.3.1. The Middle-East and Africa MicroRNA Market, by Application, 2016-2019 (USD Million)
      4. 4.7.4. The Middle-East and Africa MicroRNA Market, by End Use, 2016-2019
        1. 4.7.4.1. The Middle-East and Africa MicroRNA Market, by End Use, 2016-2019 (USD Million)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2019 (USD Million)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2019 (USD Million)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2019 (USD Million)
  5. CHAPTER 5. MicroRNA market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. Affymetrix
      1. 6.1.1. Company Overview
      2. 6.1.2. Affymetrix Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Alnylam Pharmaceuticals Inc.
      1. 6.2.1. Company Overview
      2. 6.2.2. Alnylam Pharmaceuticals Inc. Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. AstraZeneca Pharmaceuticals LP
      1. 6.3.1. Company Overview
      2. 6.3.2. AstraZeneca Pharmaceuticals LP Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Santaris Pharma
      1. 6.4.1. Company Overview
      2. 6.4.2. Santaris Pharma Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Biogen Idec Inc.
      1. 6.5.1. Company Overview
      2. 6.5.2. Biogen Idec Inc. Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Exiqon
      1. 6.6.1. Company Overview
      2. 6.6.2. Exiqon Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Pfizer Inc.
      1. 6.7.1. Company Overview
      2. 6.7.2. Pfizer Inc. Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. CBC Biomarker Center GmbH
      1. 6.8.1. Company Overview
      2. 6.8.2. CBC Biomarker Center GmbH Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Eli Lilly and Co.
      1. 6.9.1. Company Overview
      2. 6.9.2. Eli Lilly and Co. Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. F. Hoffman-La Roche
      1. 6.10.1. Company Overview
      2. 6.10.2. F. Hoffman-La Roche Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
    11. 6.11. GlaxoSmithKline
      1. 6.11.1. Company Overview
      2. 6.11.2. GlaxoSmithKline Revenue and Gross Margin
      3. 6.11.3. Product portfolio
      4. 6.11.4. Recent initiatives
    12. 6.12. Novartis AG and Merck & Co.
      1. 6.12.1. Company Overview
      2. 6.12.2. Novartis AG and Merck & Co. Revenue and Gross Margin
      3. 6.12.3. Product portfolio
      4. 6.12.4. Recent initiatives
  7. CHAPTER 7. MicroRNA — Industry Analysis
    1. 7.1. MicroRNA Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. MicroRNA Market – Attractiveness Analysis
      1. 7.4.1. By Application
      2. 7.4.2. By End Use
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global MicroRNA Market, 2016-2019 (USD Million)
        FIG. 2 Global MicroRNA Market Share, by Application, 2019 & 2026 (USD Million)
        FIG. 3 Global Clinical Diagnostics MicroRNA Market, 2016-2019 (USD Million)
        FIG. 4 Global Research MicroRNA Market, 2016-2019 (USD Million)
        FIG. 5 Global MicroRNA Market Share, by End Use, 2019 & 2026 (USD Million)
        FIG. 6 Global Research and Academic Institutes MicroRNA Market, 2016-2019 (USD Million)
        FIG. 7 Global Contract Research Organizations MicroRNA Market, 2016-2019 (USD Million)
        FIG. 8 Global Biopharmaceutical Companies MicroRNA Market, 2016-2019 (USD Million)
        FIG. 9 Global Diagnostic Centers MicroRNA Market, 2016-2019 (USD Million)
        FIG. 10 Global MicroRNA Market Share, by Region, 2019 & 2026
        FIG. 11 North America MicroRNA Market, 2016-2019
        FIG. 12 U.S. MicroRNA Market, 2016-2019
        FIG. 13 Canada MicroRNA Market, 2016-2019
        FIG. 14 Europe MicroRNA Market, 2016-2019
        FIG. 15 Germany MicroRNA Market, 2016-2019
        FIG. 16 France MicroRNA Market, 2016-2019
        FIG. 17 U.K. MicroRNA Market, 2016-2019
        FIG. 18 Italy MicroRNA Market, 2016-2019
        FIG. 19 Spain MicroRNA Market, 2016-2019
        FIG. 20 Rest of Europe MicroRNA Market, 2016-2019
        FIG. 21 Asia Pacific MicroRNA Market, 2016-2019
        FIG. 22 China MicroRNA Market, 2016-2019
        FIG. 23 Japan MicroRNA Market, 2016-2019
        FIG. 24 India MicroRNA Market, 2016-2019
        FIG. 25 South  Korea MicroRNA Market, 2016-2019
        FIG. 26 South-East Asia MicroRNA Market, 2016-2019
        FIG. 27 Rest of Asia Pacific MicroRNA Market, 2016-2019
        FIG. 28 Latin America MicroRNA Market, 2016-2019
        FIG. 29 Brazil MicroRNA Market, 2016-2019
        FIG. 30 Mexico MicroRNA Market, 2016-2019
        FIG. 31 Rest of Latin America MicroRNA Market, 2016-2019
        FIG. 32 The Middle-East and Africa MicroRNA Market, 2016-2019
        FIG. 33 GCC Countries MicroRNA Market, 2016-2019
        FIG. 34 South Africa MicroRNA Market, 2016-2019
        FIG. 35 Rest of Middle-East Africa MicroRNA Market, 2016-2019
        FIG. 36 Competitor Market Share – Revenue
        FIG. 37 Affymetrix Revenue and Growth Rate
        FIG. 38 Affymetrix Market Share
        FIG. 39 Alnylam Pharmaceuticals Inc. Revenue and Growth Rate
        FIG. 40 Alnylam Pharmaceuticals Inc. Market Share
        FIG. 41 AstraZeneca Pharmaceuticals LP Revenue and Growth Rate
        FIG. 42 AstraZeneca Pharmaceuticals LP Market Share
        FIG. 43 Santaris Pharma Revenue and Growth Rate
        FIG. 44 Santaris Pharma Market Share
        FIG. 45 Biogen Idec Inc. Revenue and Growth Rate
        FIG. 46 Biogen Idec Inc. Market Share
        FIG. 47 Exiqon Revenue and Growth Rate
        FIG. 48 Exiqon Market Share
        FIG. 49 Pfizer Inc. Revenue and Growth Rate
        FIG. 50 Pfizer Inc. Market Share
        FIG. 51 CBC Biomarker Center GmbH Revenue and Growth Rate
        FIG. 52 CBC Biomarker Center GmbH Market Share
        FIG. 53 Eli Lilly and Co. Revenue and Growth Rate
        FIG. 54 Eli Lilly and Co. Market Share
        FIG. 55 F. Hoffman-La Roche Revenue and Growth Rate
        FIG. 56 F. Hoffman-La Roche Market Share
        FIG. 57 GlaxoSmithKline Revenue and Growth Rate
        FIG. 58 GlaxoSmithKline Market Share
        FIG. 59 Novartis AG and Merck & Co. Revenue and Growth Rate
        FIG. 60 Novartis AG and Merck & Co. Market Share
        FIG. 61 Market Dynamics
        FIG. 62 Global MicroRNA – Value Chain Analysis
        FIG. 63 Technology Roadmap and Timeline
        FIG. 64 Market Attractiveness Analysis – By Application
        FIG. 65 Market Attractiveness Analysis – By End Use
        FIG. 66 Market Attractiveness Analysis – By Region
        FIG. 67 Market Channel
        FIG. 68 Marketing Channel Development Trend
        FIG. 69 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global MicroRNA Market, 2019 & 2026 (USD Million)
        TABLE 2 Global MicroRNA market, by Application, 2016-2019 (USD Million)
        TABLE 3 Global MicroRNA market, by End Use, 2016-2019 (USD Million)
        TABLE 4 Global MicroRNA market, by Region, 2016-2019 (USD Million)
        TABLE 5 North America MicroRNA Market, by Application, 2016-2019 (USD Million)
        TABLE 6 North America MicroRNA Market, by End Use, 2016-2019 (USD Million)
        TABLE 7 Europe MicroRNA Market, by Application, 2016-2019 (USD Million)
        TABLE 8 Europe MicroRNA Market, by End Use, 2016-2019 (USD Million)
        TABLE 9 Asia Pacific MicroRNA Market, by Application, 2016-2019 (USD Million)
        TABLE 10 Asia Pacific MicroRNA Market, by End Use, 2016-2019 (USD Million)
        TABLE 11 Latin America MicroRNA Market, by Application, 2016-2019 (USD Million)
        TABLE 12 Latin America MicroRNA Market, by End Use, 2016-2019 (USD Million)
        TABLE 13 The Middle-East and Africa MicroRNA Market, by Application, 2016-2019 (USD Million)
        TABLE 14 The Middle-East and Africa MicroRNA Market, by End Use, 2016-2019 (USD Million)
        TABLE 15 Global MicroRNA Market - Company Revenue Analysis 2016-2026 (USD Million)
        TABLE 16 Global MicroRNA Market - Company Revenue Share Analysis 2016-2026(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities

Key Insights from Primary Research

  • As per our analysis, the MicroRNA market is set to grow annually at a rate of around 20%
  • It was valued through primaryresearch that the MicroRNAmarket was valued at around USD 150Million in 2019
  • North Americais currently holding the largestshare among all the regions and expected to continue the trend in the upcoming period.
  • Rapid progress is expected to foster Asia Pacific growth in genomic studies and increasing use of advanced technologies.

Key Recommendations from Analysts

  • As per our analysisit was anticipated that during the forecast period application of the market will grow majorly in developed countries
  • The market value for year 2026 was estimated USD 654 Million
  • Asia-Pacific region is likely to witness fastest growth during the analysis period
  • As per our analysts, recent innovations and increasing applications are expected to contribute over the forecast period to market growth forMicroRNA.

Industry Major Market Players

Affymetrix
 Alnylam Pharmaceuticals Inc.
AstraZeneca Pharmaceuticals LP
 Santaris Pharma
 Biogen Idec Inc.
 Exiqon
 Pfizer Inc.
 CBC Biomarker Center GmbH
 Eli Lilly and Co.
 F. Hoffman-La Roche
 GlaxoSmithKline
 Novartis AG and Merck & Co.

Related Reports

Vacutainer Market By Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, and Others), By Application (Venous Blood Collection, and Capillary Blood Collection): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the vacutainer industry. The report analyzes and declares the historical and current trends analysis of the Vacutainer industry and subsequently recommends the projected tr...Read More

Mar-2020 | Price : $ 3850.00 | Pages: 189 | Report Code: ZMR-820 | Report Format:

RNAi for the Therapeutics Market by Type (siRNA, miRNA, and shRNA), and By Sales Channel (Direct & Distributor) for Cancer, Ocular Disorder, HBV and Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026

The report encompasses the forecast as well as analysis of the RNAi for the Therapeutics market on the global and regional levels. The study displays historical data of 2016 to2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). Additionally, the market growth drivers, oppo...Read More

Feb-2020 | Price : $ 3850.00 | Pages: 185 | Report Code: ZMR-503 | Report Format:

Plant Genomics Market By Type (Molecular Engineering, Genetic Engineering, and Others), By Trait (Disease Resistance, Herbicide Tolerance, Yield Improvement, and Others), By Objective (GENE Expression Profiling, DNA Extraction & Purification, DNA/RNA Sequencing, Marker-Assisted Selection, Genotyping, GMO-Trait Purity Testing, and Others), By Application (Fruits & Vegetables, Cereals & Grains, Oilseeds & Pulses, and Others), and By Region – Global Industry Analysis on Growth, Size, Share, Trends, and Forecast, 2018 – 2025

Our research analysts have used reliable market research tools to provide complete details about the global Plant Genomics market. The trusted methodologies have helped the analysts provide the global Plant Genomics market size in terms of USD Million. The report provides historical data from 2015...Read More

Jan-2020 | Price : $ 3850.00 | Pages: 180 | Report Code: ZMR-318 | Report Format:

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions